Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-15 of 15 for your search:
Drug:  lonafarnib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-SCH-1298, SPRI-C98-545-18, NCI-G99-1534

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-98115, SPRI-C98-545-12, NCI-G99-1571

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-9906030, SPRI-P00346, NCI-G99-1610

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16997, EORTC-GU-16997, EORTC-PAMM-16997, NCT00006351

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0403073-01, SPRI-P03480, NCT00098904

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AGO-OVAR 15, NCT00281515

7.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-99020, SPRI-C98-564-01, NCI-G99-1540, NCT00003956

8.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EORTC-16979, SPRI-I97-211

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16023-10051, SPRI-P01900, NCT00068757

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: ID02-221, NCT00047502

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: P01964, NCT00040547

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-16027-26023, EORTC-16027, EORTC-26023, SPRI-P03174, NCT00083096

13.

Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: 2004-0424, SPRI # P04084, NCI-2012-01311, NCT00102648

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00005027, 7009/Pro00005027, NCT00612651

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000068571, PBTC-003, SPRI-P02201, NCT00015899
New Search